Table of Contents Table of Contents
Previous Page  E109 692 Next Page
Information
Show Menu
Previous Page E109 692 Next Page
Page Background

Letter to the Editor

Re: Thomas Seisen, Benoit Peyronnet, Jose Luis

Dominguez-Escrig, et al. Oncologic Outcomes of

Kidney-sparing Surgery Versus Radical

Nephroureterectomy for Upper Tract Urothelial

Carcinoma: A Systematic Review by the EAU

Non-muscle Invasive Bladder Cancer Guidelines Panel.

Eur Urol 2016;70:1052–68

Preoperative Bladder Cancer History and Chronic Kidney

Disease Are Associated with Occult Renal Pelvis Cancer in

Preoperative Solitary Ureteral Cancer

Seisen et al

[1]

present a systemic review revealing similar

survival after kidney-sparing surgery (KSS) compared to

radical nephroureterectomy (RNU) only for low-grade and

noninvasive upper urinary tract urothelial carcinoma

(UTUC). However, selected patients with high-grade and

invasive UTUC could safely benefit from KSS when feasible.

Preoperative computed tomograpy (CT) imaging is routine-

ly performed before RNU for cancer staging. However, flat or

small lesions in the renal pelvis are difficult to detect. It has

been hypothesized that intraluminal cancer seeding can

cause UC recurrence

[2,3]

. Occult renal pelvis UC (RPUC)

may be associated with continuous tumor cell shedding,

with possible seeding on the post-ureteroureterostomy

rough surface. KSS should be carefully performed in highly

selected patients with high-grade UTUC and minimal risk of

occult UTUC.

We performed a retrospective study to identify patients

with a risk of occult RPUC among patients with preoperative

UC in a solitary ureter. From 2005 to 2012, 263 patients with

preoperative UC in a solitary ureter underwent RNU at

Kaohsiung Chang Gung Medical Center

( Table 1 )

. Preopera-

tive CT imaging was performed for all patients. Qualified

radiologists were blinded to the pathologic result and

oncologic outcome. Perioperative data, such as age, gender,

and UC risk factors including smoking history, bladder

cancer history, chronic kidney disease (CKD) stage classified

according to the glomerular filtration rate estimated via the

Modification of Diet in Renal Disease formula, and grade of

hydronephrosis, were obtained via chart review. Patholo-

gists at our institution recorded pathological features.

Patients were divided into two groups according to the

presence of occult RPUC. Perioperative data were recorded

via chart review. Multivariate binary logistic regression was

used to analyze the impact of risk factors for occult RPUC.

There were 38 patients (14%) with occult RPUC after RNU

in our series. Univariate analysis revealed that the incidence

of preoperative CKD stage

>

2 and bladder cancer history

was significantly higher among patients with occult RPUC

(

p

= 0.004 and 0.003, respectively;

Table 2 )

. Multivariate

analysis revealed that history of bladder cancer (odds ratio

[OR] 2.948, 95% confidence interval [CI] 1.378–6.308;

p

= 0.005) and preoperative CKD stage

>

2 (OR 2.207, 95%

CI 1.067–4.565;

p

= 0.033) as independent risk factors for

occult RPUC.

CKD is common in patients with UTUC and was reported

to be associated with UTUC outcome because of some

common etiologic factors such as aristolochic acid and

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) e 1 0 9 – e 1 1 0

ava ilable at

www.sciencedirect.com

journal homepage:

www.eu ropeanurology.com

Table 1 – Demographic data for patients with ureter tumor treated

with radical nephroureterectomy

Renal pelvis urothelial

carcinoma

p

value

Positive

(

n

= 38)

Negative

(

n

= 225)

Follow-up duration

Gender,

n

(%)

0.054

Male

12 (32)

110 (49)

Female

26 (68)

115 (51)

Mean age (yr)

64.63

67.62

0.088

Preoperative CKD stage,

n

(%)

0.005

Stage I

0

11 (5)

Stage II

2 (5)

44 (20)

Stage III

14 (37)

95 (42)

Stage IV

5 (13)

31 (13)

Stage V

17 (45)

44 (20)

Smoking history,

n

(%)

5 (13)

41 (18)

0.447

Bladder cancer history,

n

(%)

16 (42)

45 (20)

0.003

Hydronephrosis,

n

(%)

0.533

Grade 2

14 (37)

72 (32)

>

Grade 2

24 (63)

153 (68)

Pathology stage

5 (13)

51 (23)

0.185

T0–1

T2

T3–4

CKD = chronic kidney disease.

DOI of original article:

http://dx.doi.org/10.1016/j.eururo.2016.07.014

.

http://dx.doi.org/10.1016/j.eururo.2016.09.028

0302-2838/

#

2016 Published by Elsevier B.V. on behalf of European Association of Urology.